9/26/2023 | BKDDHY | S&P lifts U.S. Renal, rates notes, loans
|
9/6/2023 | BKDDHY | Moody’s ups U.S. Renal
|
7/28/2023 | BKDDHY | S&P drops U.S. Renal Care to D
|
7/18/2023 | BKDDHY | Moody’s slices U.S. Renal
|
7/14/2023 | BKDDHY | S&P trims U.S. Renal recovery rating
|
9/12/2022 | BKDDHY | S&P downgrades U.S. Renal
|
6/28/2022 | BKDDHY | Moody's cuts U.S. Renal Care
|
4/16/2021 | BKDDHY | S&P rates U.S. Renal Care loan B-
|
5/14/2020 | BKDDHY | S&P cuts U.S. Renal
|
7/17/2019 | BKCVDDEMIGPV | Market Commentary: Medical Properties Trust upsizes drive-by; US Renal Care slips; Inflows to asset managers continue
|
7/17/2019 | DD | Market Commentary: Mallinckrodt declines as ALS study permanently halted, dialysis names under scrutiny
|
6/14/2019 | BKCVDDEMIGPV | Market Commentary: Multi-Color moved to Monday; U.S. Renal, Radian trade up; Frontier decline continues
|
6/13/2019 | BKCVDDEMIGPV | Market Commentary: Radian, Renal Care price; MCC for Friday; Nexstar on tap; Harsco, Cumulus, Outfront in focus
|
6/10/2019 | BKDDHY | S&P rates U.S. Renal Care notes CCC+
|
6/7/2019 | BKCVDDEMIGPV | Market Commentary: Stericycle prices, trades up; Vistra Energy, Grubhub gain; Envision Healthcare hits new low
|
6/7/2019 | BKDDHY | Moody’s rates U.S. Renal Care notes Caa2
|
6/4/2019 | BKCVDDEMIGPV | Market Commentary: Stericycle on tap; U.S. Renal expected; GCI gains continue; Neiman Marcus tanks
|
12/19/2016 | BKDDHYIG | S&P revises ratings on three renal companies
|
8/20/2014 | BKDD | S&P lifts U.S. Renal to stable
|
7/24/2013 | BKDD | S&P lowers U.S. Renal debt, rates loans B, CCC+,
|
6/26/2013 | BKDD | Moody's could cut U.S. Renal loans
|
6/26/2013 | BKDD | S&P lowers U.S. Renal Care view to negative
|
6/22/2012 | BKDD | Moody's: U.S. Renal loans B1, Caa1
|
6/20/2012 | BKDD | S&P rates U.S. Renal loans B+, CCC+
|